These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 28919046)
1. FGF23 activates injury-primed renal fibroblasts via FGFR4-dependent signalling and enhancement of TGF-β autoinduction. Smith ER; Holt SG; Hewitson TD Int J Biochem Cell Biol; 2017 Nov; 92():63-78. PubMed ID: 28919046 [TBL] [Abstract][Full Text] [Related]
2. FGF23 is synthesised locally by renal tubules and activates injury-primed fibroblasts. Smith ER; Tan SJ; Holt SG; Hewitson TD Sci Rep; 2017 Jun; 7(1):3345. PubMed ID: 28611350 [TBL] [Abstract][Full Text] [Related]
3. FGF23 induced left ventricular hypertrophy mediated by FGFR4 signaling in the myocardium is attenuated by soluble Klotho in mice. Han X; Cai C; Xiao Z; Quarles LD J Mol Cell Cardiol; 2020 Jan; 138():66-74. PubMed ID: 31758962 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts. Leifheit-Nestler M; Kirchhoff F; Nespor J; Richter B; Soetje B; Klintschar M; Heineke J; Haffner D Nephrol Dial Transplant; 2018 Oct; 33(10):1722-1734. PubMed ID: 29425341 [TBL] [Abstract][Full Text] [Related]
5. Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome. Hao H; Ma S; Zheng C; Wang Q; Lin H; Chen Z; Xie J; Chen L; Chen K; Wang Y; Huang X; Cao S; Liao W; Bin J; Liao Y Aging (Albany NY); 2021 Jan; 13(2):2982-3009. PubMed ID: 33460402 [TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 and Klotho contribute to airway inflammation. Krick S; Grabner A; Baumlin N; Yanucil C; Helton S; Grosche A; Sailland J; Geraghty P; Viera L; Russell DW; Wells JM; Xu X; Gaggar A; Barnes J; King GD; Campos M; Faul C; Salathe M Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 29748308 [TBL] [Abstract][Full Text] [Related]
7. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis. Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083 [TBL] [Abstract][Full Text] [Related]
8. Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. Grabner A; Amaral AP; Schramm K; Singh S; Sloan A; Yanucil C; Li J; Shehadeh LA; Hare JM; David V; Martin A; Fornoni A; Di Marco GS; Kentrup D; Reuter S; Mayer AB; Pavenstädt H; Stypmann J; Kuhn C; Hille S; Frey N; Leifheit-Nestler M; Richter B; Haffner D; Abraham R; Bange J; Sperl B; Ullrich A; Brand M; Wolf M; Faul C Cell Metab; 2015 Dec; 22(6):1020-32. PubMed ID: 26437603 [TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Singh S; Grabner A; Yanucil C; Schramm K; Czaya B; Krick S; Czaja MJ; Bartz R; Abraham R; Di Marco GS; Brand M; Wolf M; Faul C Kidney Int; 2016 Nov; 90(5):985-996. PubMed ID: 27457912 [TBL] [Abstract][Full Text] [Related]
10. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease. Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731 [TBL] [Abstract][Full Text] [Related]
12. FGFR3 and FGFR4 do not mediate renal effects of FGF23. Liu S; Vierthaler L; Tang W; Zhou J; Quarles LD J Am Soc Nephrol; 2008 Dec; 19(12):2342-50. PubMed ID: 18753255 [TBL] [Abstract][Full Text] [Related]
13. FGFR4 does not contribute to progression of chronic kidney disease. Taylor A; Yanucil C; Musgrove J; Shi M; Ide S; Souma T; Faul C; Wolf M; Grabner A Sci Rep; 2019 Oct; 9(1):14023. PubMed ID: 31575945 [TBL] [Abstract][Full Text] [Related]
14. Klotho Lacks an FGF23-Independent Role in Mineral Homeostasis. Andrukhova O; Bayer J; Schüler C; Zeitz U; Murali SK; Ada S; Alvarez-Pez JM; Smorodchenko A; Erben RG J Bone Miner Res; 2017 Oct; 32(10):2049-2061. PubMed ID: 28600880 [TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 23 (FGF23) induces ventricular arrhythmias and prolongs QTc interval in mice in an FGF receptor 4-dependent manner. Graves JM; Vallejo JA; Hamill CS; Wang D; Ahuja R; Patel S; Faul C; Wacker MJ Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2283-H2294. PubMed ID: 33929896 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats. Leifheit-Nestler M; Grabner A; Hermann L; Richter B; Schmitz K; Fischer DC; Yanucil C; Faul C; Haffner D Nephrol Dial Transplant; 2017 Sep; 32(9):1493-1503. PubMed ID: 28339837 [TBL] [Abstract][Full Text] [Related]
17. α-Klotho's effects on mineral homeostasis are fibroblast growth factor-23 dependent. Erben RG Curr Opin Nephrol Hypertens; 2018 Jul; 27(4):229-235. PubMed ID: 29851418 [TBL] [Abstract][Full Text] [Related]